Get started
Sanofi SASanofi SASanofi SA

Sanofi SA

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Key facts today


Sanofi won EU conditional approval for Rezurock (belumosudil) to treat chronic graft‑versus‑host disease in adults and patients 12+ (≥40 kg); approval requires a confirmatory randomized study.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪98.71 B‬ EUR
Dividend yield (indicated)
5.03%
Price to earnings Ratio (TTM)
19.27
Basic EPS (TTM)
4.27 EUR
Net income (FY)
‪5.20 B‬ EUR
Revenue (FY)
‪43.63 B‬ EUR
Shares float
‪1.10 B‬
Beta (1Y)
1.09

Employees


Employees (FY)
‪76.49 K‬
Change (1Y)
‪−8.09 K‬ −9.57%
Revenue / Employee (1Y)
‪570.33 K‬ EUR
Net income / Employee (1Y)
‪64.57 K‬ EUR

About Sanofi SA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Olivier Antoine M. Charmeil
Website
sanofi.com
Headquarters
Paris
Founded
1994
IPO date
Jul 1, 2002
Identifiers
2
ISIN FR0000120578
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Check out other big names from the same industry as SAN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


4.612% YTM
Maturity date Nov 3, 2032
Coupon 4.20% (Fixed)
4.195% YTM
Maturity date Jun 19, 2028
Coupon 3.63% (Fixed)
4.149% YTM
Maturity date Nov 3, 2028
Coupon 3.80% (Fixed)
4.102% YTM
Maturity date Nov 3, 2027
Coupon 3.75% (Fixed)
3.761% YTM
Maturity date Mar 21, 2038
Coupon 1.88% (Fixed)
3.616% YTM
Maturity date Mar 21, 2034
Coupon 1.25% (Fixed)
3.386% YTM
Maturity date Jun 23, 2032
Coupon 3.00% (Fixed)
3.289% YTM
Maturity date Mar 11, 2031
Coupon 2.75% (Fixed)
3.229% YTM
Maturity date Jun 23, 2029
Coupon 2.63% (Fixed)
3.215% YTM
Maturity date Mar 21, 2030
Coupon 1.38% (Fixed)
3.190% YTM
Maturity date Apr 1, 2030
Coupon 1.50% (Fixed)

See all SAN bonds 

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight 0.24%
Market value ‪1.54 B‬
VEA
Vanguard FTSE Developed Markets ETF
Weight 0.32%
Market value ‪1.01 B‬
IEFA
iShares Core MSCI EAFE ETF
Weight 0.44%
Market value ‪724.31 M‬
EFA
iShares MSCI EAFE ETF
Weight 0.52%
Market value ‪356.02 M‬
XESX
Xtrackers EURO STOXX 50 UCITS ETF Distribution 1D
Weight 2.31%
Market value ‪295.26 M‬
XESC
Xtrackers EURO STOXX 50 UCITS ETF Capitalisation 1C
Weight 2.31%
Market value ‪295.26 M‬
EFV
iShares MSCI EAFE Value ETF
Weight 0.97%
Market value ‪267.72 M‬
VGK
Vanguard FTSEEuropean ETF
Weight 0.65%
Market value ‪266.47 M‬
EXW1
iShares Core EURO STOXX 50 UCITS ETF (DE)
Weight 2.35%
Market value ‪259.74 M‬
CACC
Multi Units France SICAV - Amundi CAC 40 UCITS ETF Acc
Weight 5.33%
Market value ‪246.37 M‬
CAC
Multi Units France Sicav - Amundi CAC 40 UCITS ETF
Weight 5.33%
Market value ‪246.37 M‬

Explore more ETFs 

Frequently asked questions


The current price of SAN is 83.09 EUR — it has increased by 1.59% in the past 24 hours. Watch Sanofi SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Sanofi SA stocks are traded under the ticker SAN.
SAN stock has risen by 7.91% compared to the previous week, the month change is a 1.70% rise, over the last year Sanofi SA has showed a −18.90% decrease.
We've gathered analysts' opinions on Sanofi SA future price: according to them, SAN price has a max estimate of 112.00 EUR and a min estimate of 80.00 EUR. Watch SAN chart and read a more detailed Sanofi SA stock forecast: see what analysts think of Sanofi SA and suggest that you do with its stocks.
SAN reached its all-time high on Mar 10, 2025 with the price of 110.88 EUR, and its all-time low was 3.75 EUR and was reached on Feb 2, 1988. View more price dynamics on SAN chart.
See other stocks reaching their highest and lowest prices.
SAN stock is 1.84% volatile and has beta coefficient of 1.09. Track Sanofi SA stock price on the chart and check out the list of the most volatile stocks — is Sanofi SA there?
Today Sanofi SA has the market capitalization of ‪98.41 B‬, it has increased by 2.44% over the last week.
Yes, you can track Sanofi SA financials in yearly and quarterly reports right on TradingView.
SAN net income for the last half-year is ‪2.08 B‬ EUR, while the previous report showed ‪3.12 B‬ EUR of net income which accounts for 0.00% change. Track more Sanofi SA financial stats to get the full picture.
Yes, SAN dividends are paid annually. The last dividend per share was 3.92 EUR. As of today, Dividend Yield (TTM)% is 4.78%. Tracking Sanofi SA dividends might help you take more informed decisions.
Sanofi SA dividend yield was 4.98% in 2025, and payout ratio reached 96.64%. The year before the numbers were 4.18% and 88.23% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 31, 2026, the company has ‪76.49 K‬ employees. See our rating of the largest employees — is Sanofi SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanofi SA EBITDA is ‪17.09 B‬ EUR, and current EBITDA margin is 39.18%. See more stats in Sanofi SA financial statements.
Like other stocks, SAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanofi SA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanofi SA stock shows the sell signal. See more of Sanofi SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.